The prognostic values of inflammation-based prognostic scores, such as the C-reactive protein to albumin ratio, neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, platelet to lymphocyte ratio, and systemic-immune-inflammation index, have been reported in various malignancies, including breast cancer (25–29). The gene discussed is ALB; the disease is breast carcinoma.